Frédérique St‐Pierre
Northwestern University · 42 works · 301 citations · h-index 9
Top works
- Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study
- Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma
- Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
- CAR T-cell therapy for relapsed/refractory non-Hodgkin's lymphoma: a comprehensive review.
- Diagnosis of hypothenar hammer syndrome in a patient with acute ulnar artery occlusion
- Anti‐ CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study
- Impact of the COVID-19 pandemic on internal medicine training in the United States: results from a national survey
- Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies
- Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma
- Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study
- Nuances of the Female Nurse-Physician Relationship: An Evolution Across Time
- Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma
- Maximizing FDG-PET/CT Utility in Staging of Follicular Lymphoma (FL): The Role of Spleen Involvement and Bone Standardized Uptake Values
- Correlation between different levels of HER2 expression in circulating tumor cells (cHER2 ratio) and metastatic behavior in stageIVaggressive breast cancer.
- Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma
- CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study
- Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
- Bone involvement on PET/CT predicts event‐free survival in follicular lymphoma Grade 3B
- A Multicenter Study Analyzing Survival and Prognostic Factors in Patients with Leukemic Phase Follicular Lymphoma
- Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408